---
title: "Spyre Therapeutics to Participate in Upcoming September Investor Conferences"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/297955409.md"
description: "Spyre Therapeutics, Inc., headquartered in Waltham, Massachusetts, shared in a press release on September 3, 2026, that they will be participating in several investor conferences. The company, listed on the NASDAQ as SYRE, aims to advance immunology treatments by providing enhanced disease management, increased longevity, and easier treatment procedures for patients. No specific details of the conferences were provided."
datetime: "2026-09-03T20:11:22.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/297955409.md)
  - [en](https://longbridge.com/en/news/297955409.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/297955409.md)
generator: "portal-rs"
---

# Spyre Therapeutics to Participate in Upcoming September Investor Conferences

Spyre Therapeutics, Inc., headquartered in Waltham, Massachusetts, shared in a press release on September 3, 2026, that they will be participating in several investor conferences. The company, listed on the NASDAQ as SYRE, aims to advance immunology treatments by providing enhanced disease management, increased longevity, and easier treatment procedures for patients. No specific details of the conferences were provided.

### Related Stocks

- [SYRE.US](https://longbridge.com/en/quote/SYRE.US.md)

## Related News & Research

- [Spyre Therapeutics CEO Turtle Cameron disposes of 15,000 common shares worth $1.31 million](https://longbridge.com/en/news/297975740.md)
- [Insider Selling: Spyre Therapeutics (NASDAQ:SYRE) Insider Sells $36,000.00 in Stock](https://longbridge.com/en/news/297984230.md)
- [This September Volatility Trade Has Worked 5 Years In a Row](https://longbridge.com/en/news/297669155.md)
- [Diversified Royalty announces $0.02375 September dividend per share](https://longbridge.com/en/news/297959336.md)
- [DoubleLine Opportunistic Credit Fund declares $0.11 September distribution per share](https://longbridge.com/en/news/297656887.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**